While the whole world is still recovering from the havoc wreaked by the ongoing Coronavirus terror, it seems like we all are going to receive some good news regarding vaccine development.
America Might Soon Get The First Round Of Vaccine
While people in America are fearing the second wave of COVID- cases, Americans might soon receive a Covid-19 vaccine as soon as 24 hours later if the FDA approves it sometime around mid-December.
Moreover, as it was announced earlier The US Food and Drug Administration’s (FDA) outside advisers will assemble on December 10th to further discuss whether to authorize the Covid-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use. Here’s a little sneak peek into the new clip to get a detailed information about the ongoing vaccine development and when is it arriving.
Dr. Moncef Slaoui, chief scientific adviser of Operation Warp Speed, says first Americans could receive a Covid-19 vaccine by December. "So I would expect, maybe, on day two after approval … hopefully the first people will be immunized across the United States." #CNNSOTU pic.twitter.com/UvQpPi0pl9
— State of the Union (@CNNSotu) November 22, 2020
There Has Been Some Impressive New Growth Amidst Second Wave Terror.
The vaccine developed by Pfizer has been displaying impressive growth and has been proven to be 95 percent effective. Moreover, Dr. Moncef Slaoui, who is the chief scientific adviser for the US government’s Operation Warp Speed has stated that the vaccine will be distributed with some proper distribution with special priority given to healthcare workers, front-line workers along with elderly people. However, nothing has been official yet and it largely depends on how effective the vaccine proves to be.
A new gaiety on the vaccine front can be a huge sign of relief as some countries are facing a second wave of pandemic terror with some even considering lockdown yet again, in this case scenario, the advent of vaccine will not help to eradicate the virus but will also save hundreds of lives as well.